News

The Shanghai Canbi news column provides information on reference preparations, pharmaceutical intermediates, development of pharmaceutical raw materials and blood products in the field of biomedicine. Access to the latest and most comprehensive medical news policies through various global medical news platforms, collect the latest medical research and development data, take you to understand the latest trends and policies of the pharmaceutical industry, stay at home to read the latest global medical news and information.

• 
  Allegro Ophthalmics Announces Positive Results of Vehicle-controlled Ex-U.S. Phase 2 Trial of ALG-1007 for the Treatment of Dry Eye Disease
  Allegro Ophthalmics, LLC, a privately held biopharmaceutical company focused on the development of novel oxidative stress stabilizers for the treatment of ocular diseases, today announced that all primary and secondary endpoints of an ex-U.S. vehicle-cont
  Tags：
  The number of readers：3796
  Source：
  2021-11-26
• 
  Janssen Licenses "Flexible Antibody" Technology from F-star in New Collab
  Clinical-stage biopharma company F-star Therapeutics announced a new partnership with Janssen Biotech on Wednesday, only one month after presenting an optimistic trial-in-progress update to the public on its tetravalent dual T-cell agonist FS120 at the Eu
  Tags：
  The number of readers：3106
  Source：
  2021-11-15
• 
  Palleon to Present Preclinical Data on Lead Immuno-Oncology Program, E-602, at SITC Annual Meeting
  WALTHAM, Mass.--(BUSINESS WIRE)--Palleon Pharmaceuticals, a company pioneering the field of glyco-immunology to treat cancer and inflammatory diseases, today announced it will present new preclinical data on the company’s lead immuno-oncology program, E
  Tags：
  The number of readers：3161
  Source：
  2021-11-09
• 
  Angel Pharmaceuticals Announces Approval of IND Application in China for ITK Inhibitor CPI-818
  Angel Pharmaceuticals Co., Ltd. ("Angel Pharma") today announced that its IND application for CPI-818, a small molecule ITK inhibitor, has been approved by the Center for Drug Evaluation (CDE) to initiate clinical trials in patients with relapsed/refracto
  Tags：
  The number of readers：1402
  Source：
  2021-11-05
• 
  Vifor Pharma and Angion report topline results from phase-III registration trial of ANG-3777 in kidney transplant patients at risk for delayed graft function
  Vifor Pharma and Angion Biomedica Corp. (NASDAQ: ANGN) today announced that the phase-III trial of Angion’s ANG-3777 did not demonstrate a statistically significant difference from placebo on the primary endpoint (eGFR at 12 months) in the population of
  Tags：
  The number of readers：1325
  Source：
  2021-11-01
• 
  At Last, FDA Signs Off on Adamis’ Opioid Overdose Drug
  Shares in Adamis Pharmaceuticals rose 31% Monday on news that the U.S. Food and Drug Administration has approved its naloxone injection Zimhi for the treatment of opioid overdose.
  Tags：
  The number of readers：1165
  Source：
  2021-10-19
• 
  Amgen and Kyowa Kirin Notch Phase II Win in Atopic Dermatitis
  Four months after forging a collaboration to develop an experimental atopic dermatitis treatment, Amgen and Japan’s Kyowa Kirin are beginning to see the fruits of that deal with positive Phase II data for AMG 451/KHK4083, a potential first-in-class anti
  Tags：
  The number of readers：1061
  Source：
  2021-10-10
• 
  Kyowa Kirin and Amgen Present Positive Late-Breaking Data from Phase 2 Study of KHK4083/AMG 451 in Adult Patients with Moderate-to-Severe Atopic Dermatitis at EADV Congress
  TOKYO & THOUSAND OAKS, Calif,--(BUSINESS WIRE)--Kyowa Kirin Co., Ltd. (TSE:4151) and Amgen (NASDAQ: AMGN) today announced that positive data from a Phase 2 study of KHK4083/AMG 451 were presented at the European Academy of Dermatology and Venereology 30th
  Tags：
  The number of readers：1098
  Source：
  2021-10-08
• 
  BIOCORP et NOVO NORDISK signent un partenariat mondial dans le domaine du diabète en santé numérique
  BIOCORP (Paris:ALCOR) (FR0012788065 – ALCOR / Éligible PEA‐PME), société française spécialisée dans le développement et la fabrication de dispositifs médicaux et de systèmes d’administration de médicaments injectables et Novo Nordisk, lead
  Tags：
  The number of readers：1290
  Source：
  2021-09-27
• 
  Saladax Biomedical annonce que Salvatore J. Salamone, Ph.D. a reçu le prestigieux prix Dr. C.E. Pippenger
  Salvatore J. Salamone, Ph.D., a reçu le prestigieux prix Dr. C.E. Pippenger durant l'assemblée annuelle 2021 de l'Association internationale de pharmacovigilance thérapeutique et de toxicologie clinique (IATDMCT) à Rome, Italie.
  Tags：
  The number of readers：1121
  Source：
  2021-09-24

Product Info

Product Name

Synonyms

CAS

Molecular Formula Upload

Contact Us

Company

Name

Tel

Email

Details

Submit

• Please fill in product name !
• CAS
• Please fill in your company information correctly!
• Please fill in liaison information correctly!
• Please fill in your telephone number correctly!
• Please fill in your email correctly!
• Please describe the problem of products!